What is polychromasia, what does it indicate, and which laboratory tests should be ordered to evaluate it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polychromasia: Definition, Clinical Significance, and Laboratory Evaluation

Polychromasia represents young reticulocytes visible on Wright-stained peripheral blood smears, indicating active bone marrow response to anemia or blood loss, and should prompt immediate evaluation with a reticulocyte count to assess the appropriateness of marrow response.

What Polychromasia Indicates

Polychromatophilic erythrocytes are immature red blood cells that retain residual RNA, appearing blue-gray on routine Wright-Giemsa staining. These cells correspond specifically to Heilmeyer groups I, II, and III reticulocytes—the youngest reticulocyte populations 1. Their presence signals:

  • Active erythropoiesis in response to anemia, hemolysis, or blood loss
  • Adequate bone marrow function and erythropoietin response
  • Recent red cell production within the past 1-2 days

The absence of polychromasia in an anemic patient is concerning and suggests inadequate marrow response, which may indicate:

  • Bone marrow failure or suppression
  • Nutritional deficiencies (iron, B12, folate)
  • Insufficient erythropoietin production (as in chronic kidney disease)
  • Inflammatory suppression of erythropoiesis

Essential Laboratory Tests to Order

When polychromasia is identified, order the following algorithmic workup:

First-Tier Tests (Order Immediately):

  1. Complete Blood Count (CBC) with differential 2

    • Evaluate all three cell lines (WBC, hemoglobin, platelets)
    • Abnormalities in ≥2 cell lines warrant hematology consultation
    • Mean corpuscular volume (MCV) helps categorize anemia type
  2. Reticulocyte count (absolute and reticulocyte index) 2

    • Confirms and quantifies the marrow response
    • Reticulocyte index adjusts for degree of anemia
    • Low count despite polychromasia suggests evolving process or inadequate response
  3. Peripheral blood smear review 3, 4, 5, 6

    • Look for: schistocytes (microangiopathic hemolysis), spherocytes (hemolysis), target cells (hemoglobinopathy/liver disease), bite cells (oxidative damage), basophilic stippling (lead poisoning, thalassemia)
    • Assess degree of anisopoikilocytosis and polychromasia severity
  4. Hemolysis markers (if hemolysis suspected) 4, 5, 6:

    • Lactate dehydrogenase (LDH) - elevated
    • Haptoglobin - decreased or undetectable
    • Indirect (unconjugated) bilirubin - elevated
    • Direct antiglobulin test (DAT/Coombs) - to exclude autoimmune hemolysis

Second-Tier Tests (Based on Initial Results):

If MCV is low (<80 fL) 2:

  • Serum ferritin (tissue iron stores)
  • Transferrin saturation (available iron for erythropoiesis)
  • Consider hemoglobin electrophoresis or HPLC for thalassemia/hemoglobinopathy 3

If hemolysis is confirmed 4, 5:

  • Direct antiglobulin test (if not already done)
  • G6PD level (after acute episode resolves)
  • Hemoglobin electrophoresis/HPLC for unstable hemoglobins 4

If cytopenias in multiple cell lines 6:

  • Consider bone marrow biopsy
  • Autoimmune workup if Evans syndrome suspected

Critical Pitfalls to Avoid

  1. Do not assume polychromasia alone means adequate response: The reticulocyte count must be appropriately elevated for the degree of anemia. A "normal" reticulocyte count in severe anemia represents inadequate response 2.

  2. Polychromasia in neonates has different reference ranges: Neonates normally have higher polychromasia and anisocytosis; use age-specific reference intervals 7.

  3. Ferritin interpretation requires clinical context: In inflammatory states or chronic kidney disease, ferritin acts as an acute-phase reactant and may be falsely elevated despite true iron deficiency. Transferrin saturation is more reliable in these settings 2.

  4. Do not delay treatment for confirmatory testing in life-threatening conditions: If thrombotic thrombocytopenic purpura (TTP) is suspected based on schistocytes, thrombocytopenia, and hemolysis, initiate plasma exchange before ADAMTS13 results return 5.

  5. Shift reticulocytes (Heilmeyer groups I and II only) are more specific markers: These represent the youngest reticulocytes not found in normal circulation and better indicate acute marrow stress response than total reticulocyte counts 1.

Related Questions

What are microcytosis, polychromasia, and spherocytes?
What is the recommended treatment and monitoring plan for Evans syndrome?
What is the recommended diagnostic and therapeutic approach to Evans syndrome?
How is Evans syndrome diagnosed?
Does hemoglobin variant analysis by high-performance liquid chromatography detect sickle cell disease and hereditary spherocytosis?
When should casting be initiated for a comminuted intra-articular distal radius fracture, and how long should the cast be maintained?
What is the differential diagnosis for a 14-year-old male who experiences elbow locking when the joint is held in flexion for a prolonged period?
In a 53‑year‑old man with combined systolic‑diastolic heart failure, persistent erythrocytosis (hemoglobin 18.3 g/dL, hematocrit 54 %, RBC 5.97 ×10^12/L), history of pulmonary sarcoidosis in remission, normal cardiac imaging and electrophysiology, and a benign 0.62‑mm gallbladder polyp, how should I proceed with management given that the hematologist declined to treat the erythrocytosis?
In a female patient with acute psychosis due to HIV-associated neurocognitive disorder and dementia who has been started on donepezil (Aricept) 5 mg at bedtime, what additional therapeutic recommendations are appropriate?
In a 30‑year‑old male, 5 ft 11 in, 130 lb, with a decade of moderate alcohol use (up to 3 drinks per occasion, rarely >14 drinks/week, ~10‑15 binge episodes) and current labs showing normal total protein, albumin, bilirubin, alkaline phosphatase, AST, ALT, platelets, and a FIB‑4 index of ~0.9, what is the likelihood that his liver is healthy and free of significant fibrosis?
What is the recommended treatment for subclavian artery stenosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.